Serum levels of soluble CD14 in scleroderma
Bruns, M.; Hofmann, C.; Herrmann, K.; Haustein, U.F.
Acta Dermato-Venereologica 76(6): 494
1996
ISSN/ISBN: 0001-5555 PMID: 8982424 Document Number: 464300
Document emailed within 1 workday
Related Documents
Maekawa, H.; Ishiyama, N.; Furuya, N.; Nakahara, K.; Saito, S.; Uchimura, H. 1997: Serum soluble CD8 and soluble interleukin-2-receptor levels during interferon therapy in chronic hepatitis C Rinsho Byori. Japanese Journal of Clinical Pathology 45(10): 1003-1007Uner, A.; Akcali, Z.; Unsal, D. 2004: Serum levels of soluble E-selectin in colorectal cancer Neoplasma 51(4): 269-274
Vassilakopoulos, T.P.; Kyrtsonis, M-Christine.; Papadogiannis, A.; Nadali, G.; Angelopoulou, M.K.; Tzenou, T.; Dimopoulou, M.N.; Siakantaris, M.P.; Kontopidou, F.N.; Kalpadakis, C.; Kokoris, S.I.; Dimitriadou, E.M.; Tsaftaridis, P.; Pizzolo, G.; Pangalis, G.A. 2005: Serum levels of soluble syndecan-1 in Hodgkin's lymphoma Anticancer Research 25(6c): 4743-4746
Sopeña, B.; Fernández-Rodríguez, C.M.; Martínez Vázquez, C.; Méndez, M.X.; de la Fuente, J.; Freire, M.; Arnillas, E.; Outon, A. 1998: Serum levels of soluble interleukin-2 receptor in alcoholic patients Anales de Medicina Interna 15(4): 189-193
Semenzato, G.; Cipriani, A.; Trentin, L.; Zambello, R.; Masciarelli, M.; Vinante, F.; Chilosi, M.; Pizzolo, G. 1987: High serum levels of soluble interleukin-2 receptors in sarcoidosis Sarcoidosis 4(1): 25-27
Zhao, S.; Guo, Y-Ying.; Ding, N.; Yang, L-Li.; Zhang, N. 2011: Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis Chinese Medical Journal 124(19): 3058-3060
Cacciola, E.; Calogero, D.; Marra, G.; Guglielmo, P. 1992: Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia Bollettino della Societa Italiana di Biologia Sperimentale 68(4): 259-262
Direskeneli, H.; Ozdogan, H.; Korkmaz, C.; Akoglu, T.; Yazici, H. 1999: Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever Journal of Rheumatology 26(9): 1983-1986
Dalboni, M.A.; Cenedeze, M.A.; Manfredi, S.R.; Cruz Andreoli, M.C.; Pavao Dos Santos, O.; Canziani, M.E.; Boim, M.A.; Goes, M.A.; Draibe, S.A.; Balakrishnan, V.; Cendoroglo, M. 2008: High serum levels of soluble Fas (sFas) in CKD patients: effects of renal clearance, reabsorption and synthesis International Journal of Artificial Organs 31(5): 405-410
Nasu, H.; Hibi, N.; Ohyashiki, J.H.; Hara, A.; Kubono, K.; Tsukada, Y.; Ando, K.; Iwama, H.; Hayashi, S.; Yahata, N.; Toyama, K.; Ohyashiki, K. 1998: Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes International Journal of Oncology 13(3): 525-530
Gotohda, N.; Iwagaki, H.; Ozaki, M.; Kinoshita, T.; Konishi, M.; Nakagohri, T.; Takahashi, S.; Saito, S.; Yagi, T.; Tanaka, N. 2008: Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis Hepato-Gastroenterology 55(85): 1400-1403
Gamra, M.M.; el-Sharkawy, E.M.; Shinondo, C. 2001: Serum levels of some cytokines and soluble adhesion molecules in normal and patients with malignant malaria in Zambia Journal of the Egyptian Society of Parasitology 31(3): 905-914
Arun, B.; Curti, B.D.; Longo, D.L.; Stevens, D.; Alvord, W.G.; Gause, B.L.; Watson, T.; Kopp, W.C.; Janik, J.E. 2000: Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia Cancer Journal From Scientific American 6(1): 21-24
Kacprzyk, F. 2002: Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis Polskie Archiwum Medycyny Wewnetrznej 107(3): 215-221
Lombardi, G.; Matera, R.; Minervini, M.M.; Cascavilla, N.; D'Arcangelo, P.; Carotenuto, M.; Di Giorgio, G.; Musto, P. 1994: Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status Haematologica 79(5): 406-412
Kargi, A.; Yalcin, A.D.; Erin, N.; Savas, B.; H. Hüseyin Polat; Gorczynski, R.M. 2012: IL8 and Serum Soluble Trail Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients With Metastatic Colon Cancer Clinical Laboratory 58(5-6): 501-505
Lissoni, P.; Barni, S.; Tancini, G.; Viviani, S.; Rovelli, F.; Rescaldani, R.; Fiorelli, G. 1989: Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms Journal of Biological Regulators and Homeostatic Agents 3(3): 131-133
Williams, A.I.; Houba, V. 1972: Soluble serum antigens of P. falciparum in Nigerians. I. Local incidence of malarial soluble serum antigens and antibodies African Journal of Medical Sciences 3(4): 295-307
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Scudla, V.; Budíková, M.; Bacovský, J.; Opíchalová, D.; Farbiaková, V. 2000: Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma Casopis Lekaru Ceskych 139(13): 401-406